The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors – a prospective study

Introduction Multiple studies suggest that cancer leads to activation of clotting and fibrinolysis pathways, elevating the risk of thromboembolic events. Kidney cancer is often complicated by clotting disorders. In this study, we hypothesized that preoperative clotting and fibrinolysis parameters ar...

Full description

Bibliographic Details
Main Authors: Krzysztof Tupikowski, Urszula Jaobsche-Polichn, Jadwiga Bittner, Kuba Ptaszkowski, Agnieszka Halon, Romuald Zdrojowy, Rajmund Adamiec, Izabela Gosk-Bierska
Format: Article
Language:English
Published: Termedia Publishing House 2021-04-01
Series:Archives of Medical Science
Subjects:
Online Access:https://www.archivesofmedicalscience.com/The-influences-of-selected-clotting-and-fibrinolysis-factors-on-survival-of-patients,128845,0,2.html
_version_ 1797435468914098176
author Krzysztof Tupikowski
Urszula Jaobsche-Polichn
Jadwiga Bittner
Kuba Ptaszkowski
Agnieszka Halon
Romuald Zdrojowy
Rajmund Adamiec
Izabela Gosk-Bierska
author_facet Krzysztof Tupikowski
Urszula Jaobsche-Polichn
Jadwiga Bittner
Kuba Ptaszkowski
Agnieszka Halon
Romuald Zdrojowy
Rajmund Adamiec
Izabela Gosk-Bierska
author_sort Krzysztof Tupikowski
collection DOAJ
description Introduction Multiple studies suggest that cancer leads to activation of clotting and fibrinolysis pathways, elevating the risk of thromboembolic events. Kidney cancer is often complicated by clotting disorders. In this study, we hypothesized that preoperative clotting and fibrinolysis parameters are altered in healthy volunteers and kidney tumor patients. We also hypothesized that these differences may be associated with survival in patients who have undergone operations due to kidney tumors. Material and methods In this study, 96 patients with kidney tumors and 30 healthy volunteers were recruited at a single university center. All patients were assessed for pre-operative serum concentrations of tissue factor (TF), tissue factor pathway inhibitor (TFPI, total TFPI, full-length TFPI, truncated TFPI), plasmin-antiplasmin complex (PAP), thrombin-antithrombin complex (TAT), von Willebrand factor (vWF), clotting factor XIII A1 (FXIIIA1), D-dimers, and fibrinogen. Additionally, standard peripheral blood morphology was evaluated. Results Malignant kidney tumors were diagnosed in 85 of 96 tumor patients. In patients with kidney tumors, there were statistically significantly higher concentrations of fibrinogen, D-dimers, TAT, PAF, TF, TFPI, vWF, FXIIIA1, and leukocyte counts compared to the control group. Statistically significant correlations were found between multiple parameters. This points to significant clotting system alterations. Cox stepwise hazard analysis showed that pre-operative fibrinogen and D-Dimer concentrations were significantly associated with survival. Conclusions In patients with kidney tumors, multiple clotting and fibrinolysis parameters are significantly altered. Routine pre-operative measures should include determination of fibrinogen and D-dimer concentrations as these markers aid in prediction of survival probability.
first_indexed 2024-03-09T10:47:28Z
format Article
id doaj.art-7c15f454b61a48569bd5f11ee2dee651
institution Directory Open Access Journal
issn 1734-1922
1896-9151
language English
last_indexed 2024-03-09T10:47:28Z
publishDate 2021-04-01
publisher Termedia Publishing House
record_format Article
series Archives of Medical Science
spelling doaj.art-7c15f454b61a48569bd5f11ee2dee6512023-12-01T09:50:30ZengTermedia Publishing HouseArchives of Medical Science1734-19221896-91512021-04-011941003101010.5114/aoms/128845128845The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors – a prospective studyKrzysztof Tupikowski0Urszula Jaobsche-Polichn1Jadwiga Bittner2Kuba Ptaszkowski3Agnieszka Halon4Romuald Zdrojowy5Rajmund Adamiec6Izabela Gosk-Bierska7Subdivision of Urology, Wroclaw Comprehensive Cancer Centre, Wroclaw, PolandDepartment of Angiology, Hypertension and Diabetology, Wroclaw Medical University, Wroclaw, PolandDepartment of Angiology, Hypertension and Diabetology, Wroclaw Medical University, Wroclaw, PolandDepartment of Clinical Biomechanics and Physiotherapy in Motor System Disorders, Wroclaw Medical University, Wroclaw, PolandDepartment of Pathomorphology and Oncological Cytology, Wroclaw Medical University, Wroclaw, PolandDepartment of Urology and Oncological Urology, Wroclaw Medical University, Wroclaw, PolandDepartment of Angiology, Hypertension and Diabetology, Wroclaw Medical University, Wroclaw, PolandDepartment of Angiology, Hypertension and Diabetology, Wroclaw Medical University, Wroclaw, PolandIntroduction Multiple studies suggest that cancer leads to activation of clotting and fibrinolysis pathways, elevating the risk of thromboembolic events. Kidney cancer is often complicated by clotting disorders. In this study, we hypothesized that preoperative clotting and fibrinolysis parameters are altered in healthy volunteers and kidney tumor patients. We also hypothesized that these differences may be associated with survival in patients who have undergone operations due to kidney tumors. Material and methods In this study, 96 patients with kidney tumors and 30 healthy volunteers were recruited at a single university center. All patients were assessed for pre-operative serum concentrations of tissue factor (TF), tissue factor pathway inhibitor (TFPI, total TFPI, full-length TFPI, truncated TFPI), plasmin-antiplasmin complex (PAP), thrombin-antithrombin complex (TAT), von Willebrand factor (vWF), clotting factor XIII A1 (FXIIIA1), D-dimers, and fibrinogen. Additionally, standard peripheral blood morphology was evaluated. Results Malignant kidney tumors were diagnosed in 85 of 96 tumor patients. In patients with kidney tumors, there were statistically significantly higher concentrations of fibrinogen, D-dimers, TAT, PAF, TF, TFPI, vWF, FXIIIA1, and leukocyte counts compared to the control group. Statistically significant correlations were found between multiple parameters. This points to significant clotting system alterations. Cox stepwise hazard analysis showed that pre-operative fibrinogen and D-Dimer concentrations were significantly associated with survival. Conclusions In patients with kidney tumors, multiple clotting and fibrinolysis parameters are significantly altered. Routine pre-operative measures should include determination of fibrinogen and D-dimer concentrations as these markers aid in prediction of survival probability.https://www.archivesofmedicalscience.com/The-influences-of-selected-clotting-and-fibrinolysis-factors-on-survival-of-patients,128845,0,2.htmlkidney tumorfibrinogend-dimertissue factorclotting factor xiii
spellingShingle Krzysztof Tupikowski
Urszula Jaobsche-Polichn
Jadwiga Bittner
Kuba Ptaszkowski
Agnieszka Halon
Romuald Zdrojowy
Rajmund Adamiec
Izabela Gosk-Bierska
The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors – a prospective study
Archives of Medical Science
kidney tumor
fibrinogen
d-dimer
tissue factor
clotting factor xiii
title The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors – a prospective study
title_full The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors – a prospective study
title_fullStr The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors – a prospective study
title_full_unstemmed The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors – a prospective study
title_short The influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors – a prospective study
title_sort influences of selected clotting and fibrinolysis factors on survival of patients with kidney tumors a prospective study
topic kidney tumor
fibrinogen
d-dimer
tissue factor
clotting factor xiii
url https://www.archivesofmedicalscience.com/The-influences-of-selected-clotting-and-fibrinolysis-factors-on-survival-of-patients,128845,0,2.html
work_keys_str_mv AT krzysztoftupikowski theinfluencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT urszulajaobschepolichn theinfluencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT jadwigabittner theinfluencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT kubaptaszkowski theinfluencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT agnieszkahalon theinfluencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT romualdzdrojowy theinfluencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT rajmundadamiec theinfluencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT izabelagoskbierska theinfluencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT krzysztoftupikowski influencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT urszulajaobschepolichn influencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT jadwigabittner influencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT kubaptaszkowski influencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT agnieszkahalon influencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT romualdzdrojowy influencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT rajmundadamiec influencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy
AT izabelagoskbierska influencesofselectedclottingandfibrinolysisfactorsonsurvivalofpatientswithkidneytumorsaprospectivestudy